Over the latest trailing 12-month period, total return cagr is N/A. The comparable SPY value is +16.94%. Year-to-date total return is N/A. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in MMED
$10,903
(1.1x return)
Invested on Mar 6, 2026
Growth of $10,000 in SPY (S&P 500)
$11,724
(1.2x return)
Invested on Mar 6, 2026
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
YTD Total Return
N/A
1-Year Total Return
+9.0%
Current Dividend Yield
N/A
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | N/A | N/A | N/A |
| 3 Years | N/A | N/A | N/A |
| 5 Years | N/A | N/A | N/A |
| 10 Years | N/A | N/A | N/A |
| 15 Years | N/A | N/A | N/A |
| 20 Years |
| N/A |
| N/A |
| N/A |
